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The calcium-sensing receptor regulates various parathyroid
gland functions, including hormone secretion, gene
transcription, and chief cell hyperplasia through Gaq- and
Gai-dependent signaling pathways. To determine the specific
function of Gaq in these processes, we generated transgenic
mice using the human parathyroid hormone promoter to
drive overexpression of a dominant negative Gaqloop
minigene to selectively disrupt Gaq function in the
parathyroid gland. The Gaqloop mRNA was highly expressed
in the parathyroid gland but not in other tissues of these
transgenic mice. Gross appearance, body weight, bone
mineral density, and survival of the transgenic mice were
indistinguishable from those of their wild-type littermates.
Adult transgenic mice, however, exhibited an increase in
parathyroid hormone mRNA and in its basal serum level as
well as in gland size. The response of the parathyroid gland
to hypocalcemia was found to be reduced in sensitivity in the
transgenic mice when compared to their wild-type controls.
Abnormalities of the parathyroid gland function in these
transgenic mice were similar to those of heterozygous
Gaqþ / and calcium sensing receptorþ / mice. These studies
demonstrate the feasibility of selectively targeting the
parathyroid gland to investigate signaling mechanisms
downstream of the calcium receptor.
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The parathyroid gland synthesizes and secretes parathyroid
hormone (PTH) in response to changes in serum-ionized
calcium concentrations. Extracellular calcium is sensed by
calcium-sensing receptor (CASR), a 7-transmembrane do-
main G-protein-coupled receptor, which is located predomi-
nately in parathyroid chief cells.1–3 CASR regulates serum
PTH levels by controlling many aspects of parathyroid gland
function, including PTH secretion, PTH gene transcription,
and parathyroid cell growth. CASR senses small changes in
extracellular calcium and regulates serum PTH levels to
maintain the serum calcium levels in a narrow range.
Ablation of CASR in mice results in hyperparathyroidism4
and the respective heterozygous and homozygous inactivating
mutation of CASR in humans causes familial hypocalciuric
hypercalcemia and neonatal severe hyperparathyroidism.4–6 In
contrast, hypoparathyroidism, which is characterized by low
circulating PTH levels, results from activating mutations of
CASR.7 These mouse genetic models and human hereditary
disorders establish CASR as essential for regulating para-
thyroid gland function and maintaining calcium home-
ostasis. Acquired hypocalcemic disorders, such as chronic
kidney disease and vitamin D deficiency, cause secondary
hyperparathyroidism, which is characterized by elevated
circulating PTH levels, increased PTH production per cell
(hypertrophy), and parathyroid gland hyperplasia. Activation
of CASR with calcimimetics has proven to be a successful
treatment of secondary hyperparathyroidism in Chronic
kidney disease.8,9
Additional advances in treating hyperparathyroidism
may be derived from a greater knowledge of the cellular
functions of the specific signaling pathways coupled to
CASR in the parathyroid gland. Studies in heterologous
cell culture systems have shown that CASR is coupled to
Gai,10 Gaq,11 and Ga12/13.12 CASR-mediated activation of
Gai and Gaq results in the inhibition of agonist-induced
cAMP accumulation and stimulation of PI-PLC-mediated
increments in inositol trisphosphate, diacylglycerol, and
intracellular calcium.13,14 CASR also activates phospholipase
A2,14,15 phospholipase D, extracellular signal-regulated
kinase,4,13–17 and Rho-dependent pathways18–20 in nonpar-
athyroid cells systems. CASR signaling is inhibited by
GRK4-dependent receptor phosphorylation and b-arrest-
in2-dependent desensitization in HEK-293 cells.19 As pri-
mary parathyroid cell cultures do not retain their phenotype
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when grown under conditions required to selectively
manipulate specific signaling pathways and are difficult to
transfect, it has not been possible to elucidate the separate
functions of Gaq and Gai-dependent signaling by directly
manipulating their expression in the parathyroid cells ex vivo.
This is an important limitation, as Ga subunits are known to
regulate both distinct and overlapping effector pathways and
biological functions in a cell-type-specific fashion.21 For
example, Gaq in many cell systems stimulates proliferation/
hyperplasia by activation of Raf/ERK1/2 pathways. In other
cell types, Gaq family members promote apoptosis by
intracellular calcium/calcineurin-dependent and/or RhoA-
dependent pathways.22 In contrast, activation of Gai, which
reduces cAMP production, exerts anti-proliferative actions in
most cell systems, but can paradoxically stimulate prolifera-
tion in cells that express the PKA responsive B-Raf
isoform.23,24
In the current studies, we evaluated the function of Gaq in
the parathyroid gland by creating a transgenic mouse line
(TgPTHpGqloop) in which the PTH promoter drives the
expression of the C-terminal peptide of Gaq, which acts as a
dominant negative, specific inhibitor specific for Gaq.
RESULTS
CASR is coupled to Gaq and Gai, and the dominant-negative
Gaqloop minigene blocks CASR-mediated signaling pathway
in vitro
Initially, we examined the role of Gaq and Gai in mediating
the actions of CASR in HEK-293 cells that coexpress CASR
and an SRE-promoter-luciferase reporter construct. CASR-
and SRE-luc-expressing HEK-293 cells were transfected with
a cDNA encoding the dominant-negative Gaqloop minigene.
This minigene that encodes a C-terminal peptide sequence of
mouse Gaq, residues 305–359, has previously been shown to
selectively disrupt Gaq in vitro and in vivo.25 We found that
extracellular calcium significantly stimulated SRE-luc activity
in the absence of the Gaqloop minigene. In contrast,
calcium-stimulated SRE-luc was significantly inhibited by
the overexpression of the Gaqloop in CASR-expressing HEK-
293 cells (Figure 1). In addition, pretreatment with pertussis
toxin, a selective irreversible inactivator of Gai/Gao,26 also
significantly inhibited extracellular calcium stimulation of
SRE-luciferase CASR-expressing HEK-293 cells (Figure 1).
Combined Gaqloop overexpression and treatment with
pertussis toxin had additive effects on CASR-stimulated
SRE activity (Figure 1), consistent with CASR coupling to
both Gaq- and Gai-dependent pathways.
Creation of TgPTHpGqloop transgenic mice
Next, we overexpressed the dominant-negative Gaqloop
minigene25 in mice using a PTH promoter construct to
achieve class-specific inhibition of Gaq in selectively in the
parathyroid gland in vivo. The targeting strategy that we used
is shown in Figure 2a. Wild-type and TgPTHpGqloop
transgenic mice were genotyped by PCR (Figure 2b) and
found to be born at the expected Mendelian frequency. In
addition, the survival, gross appearance, body weight, and
bone mineral density of TgPTHpGqloop transgenic mice were
indistinguishable from wild-type mice (data not shown). The
expression of the Gaqloop transgene was highly and
selectively expressed in the parathyroid/thyroid tissue (Figure
2c and d). We failed to detect the transgene in any other
tissue, including the heart, lung, liver, kidney, and thymus
(Figure 2c). In addition, using a C-terminal antibody to Gaq,
we confirmed the expression of the Gaqloop peptide in
protein isolated from the parathyroid/thyroid tissues
(Figure 2d). The high ratio of the intact Gaq to the Gaqloop
peptide likely reflects the disproportionate contribution
of the thyroid gland, which expresses Gaq but not the
Gaqloop transgene (Figure 2c). We failed to detect the
peptide in tissues outside the parathyroid gland (data not
shown).
Elevated basal PTH levels in TgPTHpGqloop transgenic mice
We initially examined the effect of the dominant-negative
overexpression of the Gaqloop minigene on basal serum
PTH, calcium and phosphorus levels (Table 1). We found a
significant, B2-fold increase in serum PTH levels in
TgPTHpGqloop transgenic mice compared to wild-type
controls (Table 1). However, we did not detect differences
in either serum calcium or phosphate in TgPTHpGqloop
transgenic mice. In addition, we also did not detect
any difference in urinary calcium/creatinine ratio or urinary
phosphorus/creatinine ratio between wild-type and trans-
genic mice (data not shown).
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Figure 1 | CASR is coupled to activation of Gaq and Gai. HEK-
293 stably CASR-expressing cells were cotransfected with the
constructs directing the expression of Gaqloop (corresponding to
residues 305–359 of mouse Gaq; 1.5 mg), the SRE-luciferase
reporter gene (0.5 mg) and p-cytomegalovirus-b-galactosidase
(pCMV-b-gal; 0.015 mg) per well of six-well plate. The transfection
is described in ‘Materials and Methods’. After 2 days of
transfection, quiescent cells were pretreated with vehicle or
100 ng/ml pertussis toxin for 5 h, then stimulated by 5 mM calcium
for the last 8 h. Data are shown as relative luciferase activity
reported as the percent induction, compared with the activity
under nonstimulated conditions and normalized for
b-galactosidase. Values represent the mean±s.e.m. of at least
three experiments. Values sharing the same superscript are not
significantly different at Pp0.05.
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To gain insights into the degree of Gaqloop-dependent
disruption of Gaq in the PTG and the possible differences
between parathyroid-specific targeting of Gaq and global
Gaq-deficient mice, we compared TgPTHpGqloop transgenic
mice with Gaq-deficient mice.27 These comparisons were
limited to heterozygous Gaq mutant mice Gaqþ /,27 as
homozygous Gaq/ mice are embryonic lethal. We observed
a similar twofold increase in basal serum PTH levels in 8-
week-old Gaqþ / mice compared to wild-type littermates,
without changes in serum calcium or phosphorus (Table 1),
urinary calcium/creatinine ratio or phosphorus/creatinine
(data not shown).
We also compared TgPTHpGqloop transgenic mice
and Gaqþ / mice with heterozygous CASR-deficient
(CASRþ /) mice. Although the basal PTH, calcium
and phosphorus values in wild-type animals differed
between the various groups, likely reflecting differences
in genetic background and age of the mice; the
percentage increments in PTH were similar in TgPTHpGqloop
transgenic, Gaqþ /, and CASRþ / mice (Table 1).
Loss of one CASR allele also resulted in an approximate
twofold increase in serum PTH levels, with no significant
changes in concentration of serum calcium, phosphate
(Table 1), or urinary calcium (data not shown).
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Figure 2 | Targeted expression of dominant-negative Gaqloop minigene to mouse parathyroid glands. (a) Schematic of transgenic
construct consisting of the human PTH promoter driving the expression of the dominant-negative Gaqloop minigene. (b) Genotyping of the
TgPTHpGqloop transgenic mice by PCR. The forward and reverse primers are respectively located in the 30 end of Gaq minigene and in the
downstream poly A sequence region. Tissue-restricted expression of Gaqloop transgene by RT–PCR (c) and Western blot analysis (d).
Table 1 | Comparison of serum PTH, calcium, and phosphorus in wild-type and TgPTHpGqloop transgenic mice, wild-type and
Gaq+/ heterozygous mice, and wild-type and CASR+/ heterozygous mice
Serum
PTH (pg/ml) Calcium (mg/100 ml) Phosphorus (mg/100 ml)
WT 25.426±2.478 9.142±0.201 6.433±0.445
TgPTHpGqloop 43.419±4.823* 9.458±0.274 5.793±0.281
P-value 0.0212 0.3782 0.2377
WT 10.625±1.806 7.957±0.109 4.292±0.201
Gaq+/ 20.574±3.228* 8.076±0.121 4.569±0.174
P-value 0.0128 0.481 0.3007
WT 25.213±2.994 8.097±0.172 8.267±0.379
CASR+/ 40.443±4.926* 8.551±0.144 8.244±0.272
P-value 0.0302 0.0547 0.9607
CASR, calcium sensing receptor; PTH, parathyroid hormone; WT, wild type.
Values represent mean±s.e.m. from more than six individual mice per group.
*Significant difference between WT and Gaq+/ or TgPTHpGqloop or CASR+/ group mice at Po0.05. The serum of WT and Gaq+/ or TgPTHpGqloop was obtained from 8-week-
old mice, and the serum of WT and CASR+/ was obtained from 6-week-old mice.
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Dynamic assessment of parathyroid gland function in
TgPTHpGqloop transgenic mice: response to hypo- and
hypercalcemia
To define the role of Gaq in regulating PTH secretion in the
parathyroid gland, we respectively raised or lowered serum
calcium by calcium infusions or EDTA administration. The
administration of EGTA resulted in similar reductions in serum
calcium in both wild-type and TgPTHpGqloop mice (Figure 3a).
In contrast, hypocalcemia stimulated serum PTH (Figure 3b),
but the percentage increment of PTH level was less in
TgPTHpGqloop transgenic mice (246% compared to 387% wild
type), due to their higher baseline PTH values (Figure 3b).
Administration of calcium gluconate to elevate serum calcium
(Figure 3a) resulted in similar reductions in serum PTH
between transgenic and wild-type mice (that is, reductions of
82.1% in TgPTHpGqloop transgenic mice and 77.6% in wild-
type littermates; Figure 3b). We also constructed calcium-PTH
curves to assess the sensitivity of the parathyroid glands to
changes in extracellular calcium. This analysis demonstrated
compared to wild-type mice (Figure 4a) that TgPTHpGqloop
mice had lower serum PTH levels as a function of serum
calcium (that is, reduction in slope; Figure 4b), indicating that
the overexpression of the Gaqloop resulted in parathyroid
glands that were less sensitive to changes in serum calcium.
The role of the Gaq subunit in regulating parathyroid gland
size
To examine the effect of Gaq on parathyroid gland
hyperplasia, we assessed total parathyroid gland size by
microscopic in situ visualization of mice selectively expres-
sing enhanced green fluorescent protein (eGFP) in the
parathyroid glands. These mice were created by crossing
PTH-Cre transgenic mice onto ROSA26-rtTA-IRES-EGFP
mice. These mice were intercrossed with TgPTHpGqloop mice
to create TgPTHpCre/ROSA26-rtTA-IRES-EGFP/WT and
TgPTHpCre/ROSA26-rtTA-IRES-EGFP/TgPTHpGqloop mice.
Overexpression of Gaqloop under the control of the PTH
promoter resulted in larger parathyroid glands (Figure 5a).
The increase in parathyroid gland size was confirmed in serial
histological sections of thyroid/parathyroid tissue (Figure
5b). In addition, TgPTHpGqloop mice displayed an increase in
the number of parathyroid chief cells. The level of PTH
mRNA expression was also increased in TgPTHpGqloop
transgenic mice by both reverse transcription (RT)–PCR
(Figure 6a) and real-time RT-PCR (Figure 6c). CASR mRNA
levels were also increased in the parathyroid gland from
TgPTHpGqloop transgenic mice. In contrast, there was a
decrease in the expression of CASR in the kidney of
TgPTHpGqloop mice compared to wild-type littermates
(Figure 6b and c), suggesting that primary alterations in
PTG-mediated PTH secretion can result in adaptive changes
in the expression of CASR by the kidney.
DISCUSSION
We successfully created a TgPTHpGqloop mouse in which the
PTH promoter drives the selective expression of a dominant-
negative Gaqloop minigene to the parathyroid gland. Our
strategy exploits the previously reported effects of a C-
terminal peptide of Gaq, which contains the region of the Ga
subunit that interacts with the intracellular domains of
agonist-occupied receptors and disrupt this signaling path-
way,25 to achieve parathyroid gland-specific inhibition of
Gaq-mediated signaling. Selective disruption of Gaq function
in the parathyroid gland resulted in the development of
moderately hyperparathyroidism, characterized by increased
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Figure 3 | Effects of Gaqloop on PTH secretion. WT and TgPTHpGqloop transgenic mice were subjected to EGTA-induced hypocalcemia or
calcium gluconate (Ca Gluc)-induced hypercalcemia as described in ‘Materials and Methods’. (a) Total serum calcium and (b) PTH
concentrations in wild-type (WT) and TgPTHpGqloop transgenic mice after EGTA or calcium gluconate intraperitoneal injection. Data are
mean±s.e.m. from 6 to 10 individual mice. *Significant difference between vehicle and EGTA or calcium gluconate treatment group mice at
Po0.05, respectively. The level of PTH in response to hypocalcemia was similar in wild-type and transgenic mice, but the percentage
increment of PTH level was less in TgPTHpGqloop transgenic mice than in wild-type mice (246% and 387%, respectively), due to the higher
baseline PTH values in TgPTHpGqloop transgenic mice.
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circulating PTH levels and parathyroid gland enlargement
(Figures 2–5). Moreover, the effects on serum PTH levels in
TgPTHpGqloop mice were similar to heterozygous Gaq-
deficient and CASR-deficient mice (Table 1).
CASR, through either Gaq or Gai, regulates parathyroid
cell hyperplasia, hypertrophys and PTH secretion. Our
findings suggest that the Gaq pathway is responsible for
parathyroid cell growth, as disruption of this pathway
resulted in significant parathyroid gland enlargement caused
by hyperplasia. We did not measure PTH content of the PTG,
so we do not have precise information regarding hyper-
trophy. With regard to PTH secretion, the overexpression of
the dominant-negative Gaq construct resulted in an altera-
tion in the slope of the calcium-PTH relationship, consistent
with reduced sensitivity of the parathyroid gland to secrete
PTH in response to changes in extracellular calcium
(Figure 4). The inhibition of Gaq, however, did not prevent
the maximum secretion of PTH in response to hypocalcemia,
indicating that the disruption of CASR-dependent function
was incomplete or that the enlargement of the PTG was able
to compensate for the reduced CASR function.
In contrast to our findings, the complete ablation of Gaq
and Ga11 resulted in severe hyperparathyroidism,28 similar to
that observed in homozygous CASR/ mice.29 The failure to
observe a more severe degree of hyperparathyroidism in
TgPTHpGqloop mice, therefore, likely reflects either residual
Gaq activity, the effects of the Gai, or other signaling pathways
that are not targeted by the dominant-negative Gaqloop
construct. It is also important to note that unlike the specificity
of deleting CASR, the overexpression of the dominant-negative
Gaq(305–359) construct would globally disrupt Gaq-dependent
signaling from any G-protein-coupled receptors in the
parathyroid, including purinergic receptors that are expressed
in the parathyroid gland (GEO database: GDS1086) and have
been shown to mobilize calcium in parathyroid cells.30 In any
event, there was an increase in chief cell number and amount of
PTH mRNA per gland of selective TgPTHpGqloop mice,
indicating that even less than maximal reductions in Gaq
signaling is sufficient to stimulate parathyroid gland hyper-
plasia, and PTH gene transcription.
Interestingly, unlike CASRþ / mice that had significant
increases in serum calcium compared to wild-type litter-
mates, TgPTHpGqloop mice displayed a slight but not
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Figure 4 | Relationship between serum calcium and PTH levels in wild-type and TgPTHpGqloop transgenic mice. (a) Regression analysis
showing the normal relationship between serum calcium and PTH levels in wild-type mice. (b) Overexpression of the Gaqloop transgene to
the parathyroid gland alters the slope of the serum calcium and PTH-level relationship, consistent with impaired calcium sensing.
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Figure 5 | Effects of Gaqloop on proliferation of parathyroid
glands. (a) Fluorescence microscopy images of the parathyroid
gland of control double transgenic TgPTHpCre/ROSA26-rtTA-IRES-
EGFP/WT and triple transgenic TgPTHpCre/ROSA26-rtTA-IRES-
EGFP/TgPTHpGqloop mice. Parathryroid glands express eGFP under
the control of the ROSA26 promoter (generated by crossing PTH-
Cre with ROSA26-rtTA-IRES-EGFP mice). (b) Histologic appearance
of parathyroid gland from wild-type (WT) mice and TgPTHpGqloop
sex-matched littermates. Sections were prepared from adult mice
for light microscopy and stained with H&E. The upper panels
show original magnification  10, and the lower panels show
magnification  40 of the thyroid and parathyroid glands from
wild-type mice (WT) and TgPTHpGqloop littermates. All mice are 2
months of age. Tissues are formalin fixed and have been stained
with H&E.
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significant increase in serum calcium (Table 1). The reason
for the lack of relative hypercalcemia in the TgPTHpGqloop
mice may reflect differences in CASR function in the kidney,
which is disrupted in the CASRþ / mice but intact in the
TgPTHpGqloop mice. The downregulation of CASR message
levels in the kidney of TgPTHpGqloop mice is also consistent
with ligand-dependent downregulation of CASR. However,
we failed to observed differences in the urinary calcium/Cr
ratio of CASRþ / mice and TgPTHpGqloop compared to their
respective wild-type control mice. The mechanism under-
lying the decrease in CASR expression in the kidney is not
known. However, as PTH acting on PTH receptors in the
distal convoluted tubule and connecting tubule stimulates
active renal Ca2þ reabsorption by the kidney;31 and CASR
acting in the thick ascending limb of the loop of Henle
inhibits calcium reabsorption,32 the observed reduction of
CASR would work in concert with elevated PTH to limit
renal calcium excretion. In addition, we failed to observe any
effects of elevated PTH on bone mineral density. We did not
perform a more detailed histomorphometic analysis to detect
the effects of elevated PTH on bone.
We also observed an increase in CASR message expression
in the parathyroid glands of TgPTHpGqloop mice (Figure 5).
From our studies, we cannot determine if this represents an
upregulation of CASR expression by disruption of the Gaq
signaling or simply reflects the increase in parathyroid
growth. The increase in CASR expression in our studies,
however, are opposite to the relative reduction of CASR
expression in parathyroids of double Gaq/Ga11 knockout
mice.28 In addition, it is possible that the increase in CASR
expression may have mitigated the increase in PTH, thereby
contributing to the milder degree of hyperparathyroidism in
TgPTHpGqloop mice.
The current studies do not define the role of Gai in
mediating the effects of CASR on parathyroid cell function.
However, the greater effect of Gaq on gland size and PTH
mRNA expression is consistent with its role in cell
proliferation and hypertrophy, whereas the relative preserva-
tion of maximal PTH secretion in TgPTHpGqloop mice
implicates a possible role of Gai in the PTH secretion.
Further studies that target Gai are needed to explore the
likelihood that different Ga subunits have both distinct and
overlapping roles in the parathyroid gland.
In conclusion, we have successfully developed a mouse
model of hyperparathyroidism caused by parathyroid-specific
inhibition of the Gaq. In addition, we show that Gaq has
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important effects to regulate parathyroid cell growth and
PTH mRNA levels, as well as PTH secretion. Using a similar
approach to target Gai and other pathways in parathyroid
gland will lead to new insights into specific molecular
mechanisms controlling parathyroid gland function in a
biologically relevant context.
MATERIALS AND METHODS
Cell culture
HEK-293 cells were grown in Dulbecco’s modified Eagle’s medium
supplemented with 10% fetal calf serum and 1% penicillin/strepto-
mycin at 37 1C in a humidified atmosphere of 95% air and 5% CO2.
Sources and construction of expression plasmids
The rat CASR cDNA was obtained from Dr AM Snowman and
Dr SH Snyder33 and subcloned in the mammalian expression vector
pcDNA3 (Invitrogen, Carlsbad, CA, USA) as previously described.34
The Gaq(305–359) minigene construct that correspond to the
C-terminal peptide sequence of Gaq residues 305–359 was
kindly provided by Dr Robert J Lefkowitz from Duke University.25
We used the previously described SRE-luciferase plasmid DNA as
reporter gene.35
Transient and stable transfection
For these studies, all plasmid DNAs as described above, were
prepared using the EndoFree plasmid maxi kit (Qiagen Inc.,
Valencia, CA, USA). Transient transfections were preformed as
follows: 2 105 HEK-293 were plated in the six-well plate and
incubated overnight at 37 1C. A DNA-liposome complex was
prepared by mixing DNA of the SRE-luciferase reporter plasmid,
pCMV-b-gal and other expression vector as indicated with TransFast
transfection reagent (1:2 DNA/TransFast transfection reagent;
Promega Corp., Madison, WI, USA) in Opti-MEM I reduced serum
medium (Life Technologies, Inc., Carlsbad, CA, USA). The total
plasmid DNA was equalized in each well of six-well plate by
adjusting the total amount of DNA to 2 mg per well with the empty
vector.
Assessment of agonist-stimulated SRE activity
Quiescence of transfected cells was achieved in subconfluent
cultures by incubation for 24 h in serum-free Dulbecco’s
modified Eagle’s medium/F12 containing 0.1% bovine serum
albumin. After 2 days of transfection, quiescent cells were treated
with vehicle or stimulated for the last 8 h with appropriate agonists
as indicated. Luciferase activity was assessed after 8 h of stimulation
and measured using the luciferase assay system (Promega Corp.,
Madison, WI, USA), following the manufacturer’s protocol using a
BG-luminometer (Gem Biomedical Inc., Hamden, CT, USA).
Gaq knockout mice
Mice were maintained and used in accordance with recommenda-
tions in the Guide for the Care and Use of Laboratory Animals,
prepared by the Institute on Laboratory Animal Resources, National
Research Council (DHHS Publication NIH 86–23, 1985), and by
guidelines established by the institutional animal care and use
committee of University of Kansas Medical Center.
Gaq knockout mice were obtained from Dr Offermanns of Freie
Universita¨t Berlin, Germany.27 TgPTHCre (ref. 36) and ROSA26-
rtTA-IRES-EGFP mice37 were purchased from The Jackson Labora-
tory (Bar Harbor, ME, USA).
Generation of transgenic mice
The transgene was constructed in the pW1 vector, which contains a
multiple cloning site and an SV40 intron plus polyadenylation site
flanked by the rare restriction enzyme sites NotI and SfiI.38 A 5221-
bp fragment of the hPTH promoter39 was released from pBS-50PTH
by restriction endonuclease digestion and subcloned into the
blunted SacI site and SmaI site of pW1, thereby generating pW1-
50hPTHp. The pW1-50hPTHp-Gaqloop construct was constructed
by inserting a 165-bp fragment of the C-terminal peptide sequence
of mouse Gaq, residues 305–359,25 was generated by RT–PCR and
subcloned into XhoI site and BamHI site of pW1-50hPTHp. Plasmid
DNA was first isolated using the Qiafilter Maxi Kit (Qiagen,
Valencia, CA, USA), followed by CsCl banding. 50hPTHp-Gaqloop
DNA for microinjection was released from the vector backbone
using NotI and SfiI, separated by agarose gel, and then gel-purified
using Qiaex II gel extraction (Qiagen) according to the manufac-
turer’s instructions. 50hPTHp-Gaqloop DNA was further purified
using the EndoFree Kit (Qiagen) to remove endotoxins and
quantified using the PicoGreen Assay Kit (Molecular Probes,
Carlsbad, CA, USA). Transgenic mice were made by the Duke
Transgenic Facility by microinjecting C57Bl6F1/J fertilized mouse
eggs with DNA at a concentration of 2–3 ng/ml according to standard
techniques.40 For genotyping of the TgPTHpGqloop transgenic mice,
we used a primer set that forward primer (mouseGaqloop.For:
acgcgtcgaccatggctcgagaattcatcc) is located in the 30 end of Gaq
minigene and reverse primer (SV40pA.Rev2: atcagttccataggttggaatc) is
located in the downstream poly A sequence region to genotype the
TgPTHpGqloop transgenic mice by PCR.
To create triple transgenic mice, we used the following mouse
breeding strategies. First, we mated TgPTHCre and TgPTHpGqloop
transgenic mice to create the double TgPTHCre/TgPTHpGqloop
transgenic mice, then mated the ROSA26-rtTA-IRES-EGFP male
homozygous mice with double heterozygous TgPTHCre/
TgPTHpGqloop transgenic female mice to generate triple transgenic
TgPTHpCre/ROSA26-rtTA-IRES-EGFP/TgPTHpGqloop, and their lit-
termates double transgenic TgPTHpCre/ROSA26-rtTA-IRES-EGFP/
WT mice. Mice were genotyped by PCR using the following primer
sets. For TgPTHpGqloop transgene, the forward primer: mouseGaq-
loop. For acgcgtcgaccatggctcgagaattcatcc and reverse primer:
SV40pA.Rev2: atcagttccataggttggaatc. For TgPTHpCre transgene,
the PTH-Cre wt1: ctaggccacagaattgaaagatct and PTH-Cre wt2:
gtaggtggaaattctagcatcatcc as internal control for wild-type mice. The
PTH-Cre tgp1: gcggtctggcagtaaaaactatc and PTH-Cre tgp2: gtgaaacagc
attgctgtcactt for the Cre transgene. For ROSA26-rtTA-IRES-EGFP mice,
the oIMR0872: aagttcatctgcaccaccg and oIMR1416: tccttgaagaagatggtgcg
amplifying eGFP transgene, the oIMR3621: cgtgatctgcaactccagtc and
oIMR3622: ggagcgggagaaatggatatg amplifying wild-type allele.
PIXImus bone mineral density analysis
Bone mineral density of whole skeletons and femurs were assessed at
8 weeks of age using a PIXImus bone densitometer (Lunar Corp.,
Madison, WI, USA) as previously described.41
Serum and urine biochemistries
Serum and urinary calcium and phosphate as well as serum PTH
were measured, respectively, using Calcium Liquicolor (Stanbio
Laboratory, Boerne, TX, USA), the phosphomolybdate-ascorbic acid
method, and the Mouse Intact PTH ELISA Kit (Immunotopics, San
Clemente, CA, USA) as described previously.41 Creatinine was
measured by the colorimetric alkaline picrate method (Sigma kit
555, Sigma, St. Louis, MO, USA).
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Quantitative real-time RT-PCR and RT–PCR
For quantitative real-time RT-PCR, 2.0 mg total RNA isolated from
kidney and thyroid include parathyroid of 8-week-old wild-type and
TgPTHpGqloop transgenic mice was reverse transcribed as de-
scribed.42 PCR reactions contained 100 ng template, 300 nM each
forward and reverse primer and 1X iQ SYBR Green Supermix (Bio-
Rad, Hercules, CA, USA) in 50 ml. Samples were amplified for 40
cycles in an iCycler iQ Real-Time PCR Detection System with an
initial melt at 95 1C for 10 min followed by 40 cycles of 95 1C for 15 s
and 60 1C for 1 min. PCR product accumulation was monitored at
multiple points during each cycle by measuring the increase in
fluorescence caused by the binding of SybrGreen I to dsDNA. The
threshold cycle (Ct) of tested-gene product from the indicated
genotype was normalized to the Ct for cyclophilin A.
Reverse transcription–PCR was done using two-step RNA PCR
(PerkinElmer, Waltham, MA, USA). In separate reactions, 2.0 mg of
DNase-treated total RNA was reverse-transcribed into cDNA with
the respective reverse primers specified below and Moloney murine
leukemia virus reverse transcriptase (Life Technologies Inc.,
Carlsbad, CA, USA). The products of first-strand cDNA synthesis
were directly amplified by PCR using AmpliTaq DNA polymerase
(PerkinElmer). The following primer sets were used to amplify
targeting genes. For mouse PTH gene, PTH.26.For: agtccaattcatcag
ttgtc and PTH.235.Rev: atgcataagctgtatttcac. For mouse CASR gene,
mCASR.For: tcgagaccccttacatggac and mCASR.Rev: aaattcaggtgccgta
ggtg. For housekeeping gene control G3PDH gene, G3PDH.F143:
gaccccttcattgacctcaactaca and G3PDH.R1050: ggtcttactccttggaggcc
atgt.
Western blot
Mouse parathyroid gland lysates were denatured in Laemmli sample
buffer, then resolved on NuPAGE Novex 12% Bis-Tris gels and
transferred to nitrocellulose membrane (Invitrogen). Filters were
probed with rabbit polyclonal antisera raised to the Gaq C terminus
(amino acids 341–359; Santa Cruz Biotechnology, Santa Cruz, CA,
USA), and anti-rabbit secondary antibody (Cell Signaling Technol-
ogy, Boston, MA, USA). The immunostained bands will be
visualized using an ECL plus Western Blotting Detection System
following manufacturer’s instructions (Amersham, Piscataway,
NJ, USA).
Parathyroid gland histological analysis
For histological analysis, we have found it to be most reliable to
obtain an in-block section of the mouse neck to include the thyroid,
parathyroid glands, trachea, and surrounding muscle and soft tissue.
The resected tracheal blocks from wild-type and TgPTHpGqloop
transgenic mice were dissected, dehydrated, embedded in paraffin,
sectioned (8 mm), and stained hematoxylin/eosin.
PTH–calcium relationship analysis by intraperitoneal
injection method
After fasting for 5–6 h, each mouse was administered a single
intraperitoneal injection of ether 300mmol/kg body weight of EGTA
or calcium gluconate. The blood samples were collected 30 min after
the administration of EGTA and 1 h after the administration of
calcium gluconate for measurement of serum PTH and total
calcium levels.43
Statistical analysis
We evaluated differences between groups by one-way analysis of
variance. All values are expressed as means±s.e.m. All computations
were performed using the Statgraphic statistical graphics system
(STSC Inc., Rockville, MD, USA).
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